Publications:  Dr Giulia de Falco

De Falco G(2018). Current understanding of the role and regulation of miRNAs in Burkitt lymphoma. Blood and Lymphatic Cancer : Targets and Therapy

Mundo L, Ambrosio MR, Picciolini M, Lo Bello G, Gazaneo S, Del Porro L, Lazzi S, Navari M et al.(2017). Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases. Front Microbiol vol. 8, 229-229.

Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, Bellan C, Rossi M et al.(2016). Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget vol. 7, (1) 224-240.

Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A, De Falco G, Ambrosio MR et al.(2016). Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma. American Journal of Clinical Pathology vol. 145, (1) 116-127.

De Falco G, Ambrosio MR, Fuligni F, Onnis A, Bellan C, Rocca BJ, Navari M, Etebari M et al.(2015). Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. BMC Cancer vol. 15, (1)

Ambrosio MR, De Falco G, Rocca BJ, Barone A, Amato T, Bellan C, Lazzi S, Leoncini L(2015). Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity. Virchows Archiv vol. 467, (4) 471-480.

Rogena EA, Simbiri KO, De Falco G, Leoncini L, Ayers L, Nyagol J(2015). A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000-2011 at Kenyatta National Hospital, Kenya. Infectious Agents and Cancer vol. 10, (1)

Ambrosio MR, de Falco G, de Falco G, Rocca BJ, Rocca BJ, Barone A, Amato T, Bellan C et al.(2015). Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity. Virchows Archiv

Hijazi K, Cuppone AM, Smith K, Stincarelli MA, Ekeruche-Makinde J, De Falco G, Hold GL, Shattock R et al.(2015). Expression of genes for drug transporters in the human female genital tract and modulatory effect of antiretroviral drugs. PLoS ONE vol. 10, (6)

Rocca BJ, Ginori A, Barone A, Calandra C, Crivelli F, De Falco G, Gazaneo S, Tripodi S et al.(2015). Translationally controlled tumor protein in prostatic adenocarcinoma: Correlation with tumor grading and treatment-related changes. BioMed Research International vol. 2015,

Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, Zairis S, Gazaneo S et al.(2015). Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. PLoS Pathogens vol. 11, (10)

Ambrosio MR, Rocca BJ, Barone A, Onorati M, Mundo L, Crivelli F, Di Nuovo F, De Falco G et al.(2015). Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma. BioMed Research International vol. 2015,

Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C, De Falco G et al.(2015). GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics vol. 23, (2) 195-201.

Navari M, Etebari M, Falco GD, Ambrosio MR, Gibellini D, Leoncini L, Piccaluga PP(2015). The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. Frontiers in Microbiology vol. 6, (JUN)

Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G et al.(2015). The tumor virus landscape of AIDS-related lymphomas. Blood vol. 125, (20) e14-e22.

Luzzi A, Morettini F, Gazaneo S, Mundo L, Onnis A, Mannucci S, Rogena EA, Bellan C et al.(2014). HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Infectious Agents and Cancer vol. 9, (1)

Ambrosio MR, De Falco G, Gozzetti A, Rocca BJ, Amato T, Mourmouras V, Gazaneo S, Mundo L et al.(2014). Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. Haematologica vol. 99, (11) e235-e237.

Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C, De Falco G et al.(2014). GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics

Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C et al.(2014). The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agents and Cancer vol. 9, (1)

Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M, De Falco G et al.(2014). Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Frontiers in Microbiology vol. 5, (DEC)

De Falco G, Gazaneo S, Mundo L, Volule J, Leoncini L, Moormann A (2013). Detection of the EBV-encoded Bart-6-3p in sera from endemic Burkitt lymphoma patients and malaria-exposed healthy controls: A possible biomarker?. VIRCHOWS ARCHIV. vol. 463, 317-318.

De Falco G, Navari M, Ambrosio MR, Di Lisio L, Onnis A, Martinez N, Leon EA, Bellan C et al. (2013). EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours. VIRCHOWS ARCHIV. vol. 463, 318-318.

De Falco G, Ambrosio MR, Piccaluga PP, Doglioni C, Rocca BJ, Onorati M, Malagnino V, Naresh K et al. (2013). The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: Adipophilin. VIRCHOWS ARCHIV. vol. 463, 136-136.

Savino MT, Ulivieri C, Emmi G, Prisco D, de Falco G, Ortensi B, Beccastrini E, Emmi L et al.(2013). The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. Journal of Leukocyte Biology vol. 93, (4) 549-559.

De Falco G, Videtta AD(2013). Clinical criteria for familial gastric cancer definition. Spotlight on Familial and Hereditary Gastric Cancer,

Torricelli M, Novembri R, Conti N, De Falco G, De Bonis M, Petraglia F(2012). Correlation with placental kisspeptin in postterm pregnancy and apoptosis. Reproductive Sciences vol. 19, (10) 1133-1137.

Rogena EA, Luzzi A, Morettini F, Onnis A, Mannucci S, Bellan C, Mwanda W, Leoncini L et al. (2012). DNMT over-expression based on microrna modulation in HIV-related aggressive B-cell lymphomas. HISTOPATHOLOGY. vol. 61, 162-162.

Rogena EA, Di Lisio L, Navari M, Onnis A, Martinez N, De Falco G, Leon EA, Montes-Moreno S et al. (2012). EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours. HISTOPATHOLOGY. vol. 61, 162-163.

Rogena EA, Onnis A, Morettini F, Fuligni F, De Falco G, Bellan C, Piccaluga P, Leoncini L (2012). MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt Lymphoma cases. HISTOPATHOLOGY. vol. 61, 162-162.

Schurfeld K, Calbi V, De Falco G, Ogwang M, Mwanda M, Leoncini L (2012). Project Uganda and haemopathology: St. Mary's Hospital Lacor, Gulu, Uganda. HISTOPATHOLOGY. vol. 61, 65-65.

Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M, De Falco G, Calbi V et al. (2012). The alteration of lipid metabolism in Burkitt lymphoma identifies a novel diagnostic marker: the adipophilin. HISTOPATHOLOGY. vol. 61, 120-120.

De Falco G, Luzzi A, Morettini F, Onnis A, Mannucci S, Rogena E, Bellan C, Mwanda W et al. (2012). DNMT over-expression based on microRNA modulation in HIV-related aggressive B-cell lymphomas. VIRCHOWS ARCHIV. vol. 461, S164-S164.

De Falco G, Navari M, Onnis A, Di Lisio L, Martinez N, Leon EA, Montes-Moreno S, Rogena E et al. (2012). EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours. VIRCHOWS ARCHIV. vol. 461, S164-S164.

De Falco G, Onnis A, Morettini F, Fuligni F, Bellan C, Rogena E, Piccaluga PP, Leoncini L (2012). MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt Lymphoma cases. VIRCHOWS ARCHIV. vol. 461, S30-S30.

De Falco G, Schurfeld K, Calbi V, Ogwang M, Mwanda M, Leoncini L (2012). Project Uganda and haemopathology: St. Mary's Hospital Lacor, Gulu, Uganda. VIRCHOWS ARCHIV. vol. 461, S127-S127.

Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M, De Falco G, Calbi V et al.(2012). The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin. PLoS ONE vol. 7, (8)

Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S, De Falco G, Vigorito E, Leoncini L(2012). Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer Journal vol. 2, (8)

Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG et al.(2012). EBV reactivation and chromosomal polysomies: Euphorbia tirucalli as a possible cofactor in endemic Burkitt lymphoma. Advances in Hematology vol. 2012,

Cozzi M, Giorgi F, Marcelli E, Pentimalli F, Forte IM, Schenone S, D'Urso V, De Falco G et al.(2012). Antitumor activity of new pyrazolo[3,4-d] pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. Cell Cycle vol. 11, (5) 1029-1039.

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J et al.(2011). The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia vol. 25, (12) 1869-1876.

Rogena EA, De Falco G, Schurfeld K, Leoncini L(2011). A review of the trends of lymphomas in the equatorial belt of Africa. Hematological Oncology vol. 29, (3) 111-115.

De Falco G, Mannucci S, Carugi A, Luzzi A, Gozzetti A, Leoncini L, Van den Bosch CA (2011). Euphorbia tirucalli as a possible cofactor in inducing EBV-driven malignant transformation. VIRCHOWS ARCHIV. vol. 459, S315-S315.

De Falco G, Luzzi A, Morettini F, Pinnacchio V, Onnis A, Bellan C, Leoncini L (2011). MicroRNA-induced DNA methyltransferase upregulation leads to aberrant hypermethylation in HIV-positive aggressive B-cell lymphomas. VIRCHOWS ARCHIV. vol. 459, S315-S316.

Piccaluga P, De Falco G, Rossi M, Laginestra M, Sapienza M, Bellan C, Lazzi S, Tumwine L et al. (2011). INTEGRATED MOLECULAR PROFILE OF BURKITT LYMPHOMA. ANNALS OF ONCOLOGY. vol. 22, 208-208.

Onnis A, De Falco G, Bellan C, Morettini F, Rogena EA, Leoncini L (2011). MICRORNA EXPRESSION PROFILE IDENTIFIES A DIFFERENT SIGNATURE BETWEEN MYC TRANSLOCATION-POSITIVE AND NEGATIVE BURKITT LYMPHOMA CASES. ANNALS OF ONCOLOGY. vol. 22, 151-151.

Di Lisio L, Onnis A, Martinez N, De Falco G, Andres Leon E, Montes-Moreno S, Bellan C, Tumwine L et al. (2011). NEW INSIGHTS INTO THE PATHOGENESIS OF BURKITT LYMPHOMA: EBV-ENCODED AND HUMAN MICRORNA PROFILING. ANNALS OF ONCOLOGY. vol. 22, 151-151.

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Horn H et al. (2011). THE DIFFERENT EPIDEMIOLOGIC SUBTYPES OF BURKITT LYMPHOMA SHARE A LARGELY HOMOGENOUS MICRO RNA PROFILE DISTINCT FROM DIFFUSE LARGE B-CELL LYMPHOMA. ANNALS OF ONCOLOGY. vol. 22, 150-150.

De Falco G, Rogena EA, Leoncini L(2011). Infectious agents and lymphoma. Semin Diagn Pathol vol. 28, (2) 178-187.

Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C, Leucci E, Onnis A et al.(2011). Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood vol. 117, (13) 3596-3608.

Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Astolfi A, Agostinelli C, Leucci E, Onnis A et al. (2010). Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes. BLOOD. vol. 116, 1034-1034.

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J et al. (2010). The different epidemiologic subtypes of Burkitt Lymphoma share a largely homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. ONKOLOGIE. vol. 33, 46-46.

Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L(2010). Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One vol. 5, (9)

Leoncini L, Lazzi S, De Falco G, Bellan C, Onnis A, Mourmouras V (2010). New approaches to molecular classification of lymphomas. VIRCHOWS ARCHIV. vol. 457, 119-119.

De Falco G, Luzzi A, Morettini F, Onnis A, Leoncini L (2010). Interplay between HIV and microRNAs in AIDS-related lymphomas. RETROVIROLOGY. vol. 7, 37-37.

Capitani N, Lucherini OM, Sozzi E, Ferro M, Giommoni N, Finetti F, De Falco G, Cencini E et al.(2010). Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood vol. 115, (18) 3726-3736.

Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, Luzzi A, Giorgi F, Hadjistilianou T et al.(2010). Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol vol. 223, (1) 143-150.

Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A, Costanzo V, Cerino G et al.(2010). B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer vol. 126, (6) 1316-1326.

Carugi A, Onnis A, Antonicelli G, Rossi B, Mannucci S, Luzzi A, Lazzi S, Bellan C et al.(2010). Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples. Hematol Oncol vol. 28, (1) 20-26.

De Falco G, Antonicelli G, Onnis A, Lazzi S, Bellan C, Leoncini L(2009). Role of EBV in microRNA dysregulation in Burkitt lymphoma. Semin Cancer Biol vol. 19, (6) 401-406.

Baldari CT, Capitani N, Lucherini OM, Sozzi E, Ferro M, Giommoni N, Finetti F, De Falco G et al. (2009). Impaired Expression of p66Shc, a Novel Regulator of B-Cell Survival, in Chronic Lymphocytic Leukemia. BLOOD. vol. 114, 331-331.

Lazzi S, Bellan C, Onnis A, De Falco G, Sayed S, Kostopoulos I, Onorati M, D'Amuri A et al.(2009). Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. Hum Pathol vol. 40, (9) 1252-1261.

Carugi A, Onnis A, Antonicelli G, Rossi B, Mannucci S, Luzzi A, Lazzi S, Bellan C et al. (2009). Geographic variation and environmental conditions as cofactors in chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples. VIRCHOWS ARCHIV. vol. 455, 444-444.

De Falco G, Luzzi A, Morettini F, Onnis A, Bellan C, Leoncini L (2009). MicroRNA deregulation in HIV-related lymphoid malignancies. VIRCHOWS ARCHIV. vol. 455, 445-445.

Onnis A, Antonicelli G, Lazzi S, De Falco G, Leoncini L (2009). Myc disregulation relies on miRNA altered expression. VIRCHOWS ARCHIV. vol. 455, 444-445.

Piccaluga P-P, Rossi M, De Falco G, Esposito A, Tazzari PL, Ricci F, Agostinelli C, Righi S et al. (2009). PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. CANCER RESEARCH. vol. 69,

Torricelli M, Voltolini C, Galleri L, Bloise E, Biliotti G, De Falco G, De Bonis M, Luisi S et al. (2009). Kisspeptin Modulates Placental Cells Apoptosis at Term and Preterm Labor. REPRODUCTIVE SCIENCES. vol. 16, 166A-166A.

Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J et al.(2008). MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol vol. 216, (4) 440-450.

Giacinti C, Musarò A, De Falco G, Jourdan I, Molinaro M, Bagella L, Simone C, Giordano A(2008). Cdk9-55: a new player in muscle regeneration. J Cell Physiol vol. 216, (3) 576-582.

Nyagol J, De Falco G, Lazzi S, Luzzi A, Cerino G, Shaheen S, Palummo N, Bellan C et al.(2008). HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. J Hematop vol. 1, (1) 3-10.

Piccaluga PP, De Falco G, Leucci E, Mwanda W, Leoncini L, Pileri SA (2008). RBL2/P130 NETWORK ABNORMALITIES IN ENDEMIC BURKITT'S LYMPHOMA EXPLORED BY GENE EXPRESSION ANALYSIS. HAEMATOLOGICA. vol. 93, 355-355.

Piccaluga PP, De Falco G, Leucci E, Mwanda W, Leoncini L, Pileri SA (2008). RBL2/P130 NETWORK ABNORMALITIES IN ENDEMIC BURKITT'S LYMPHOMA EXPLORED BY GENE EXPRESSION ANALYSIS. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 355-355.

De Falco G, Cerino G, Leucci E, Nyagol J, Cocco M, Onnis A, Tosi P, Giordano A et al. (2008). Role of chromatin remodeling mediated by the HIV-1 Tat protein in the genesis of the HIV-1-associated malignancies. VIRCHOWS ARCHIV. vol. 452, S43-S43.

De Falco G, Leucci E, Onnis A, Bellan C, Tigli C, Wirths S, Cerino G, Cocco M et al.(2008). Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells. J Cell Physiol vol. 215, (1) 276-282.

Onnis A, Leucci E, Cocco M, Van PC, Bellan C, Van AR, De Falco G, Nyagol J et al. (2008). MYC negative classical Burkitt Lymphoma: Alternative pathogenetic mechanisms. CELLULAR ONCOLOGY. vol. 30, 269-269.

De Falco G, Giordano A(2007). Skin banks and the state of the art of research in Europe and United States. Rivista Italiana di Chirurgia Plastica vol. 39, (3-4)

Acquaviva A, Onnis A, Luzzi A, Carugi A, Tod P, Tosi P, Giordano A, De Falco G (2007). PRB2/P130: A new candidate of retinoblastoma genes. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 92, 54-54.

Torricelli M, Giovannelli A, Leucci E, Florio P, De Falco G, Torres PB, Reis FM, Leoncini L et al.(2007). Placental neurokinin B mRNA expression increases at preterm labor. Placenta vol. 28, (10) 1020-1023.

Bardelli M, Leucci E, Schürfeld K, Bellan C, Passiatore G, Rocchigiani M, Bartolommei S, Orlandini M et al.(2007). VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. Leuk Lymphoma vol. 48, (10) 2014-2021.

De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J et al.(2007). Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood vol. 110, (4) 1301-1307.

Leucci E, Cocco M, Van Cleef P, Bellan C, Van Rijk A, De Falco G, Orinis A, Nyagol J et al. (2007). Altered expression of mirnas in c-Myc negative Burkitt lymphoma cases. VIRCHOWS ARCHIV. vol. 451, 119-119.

Bellan C, Lazzi S, Roncador G, Amato T, De Falco G, Leucci E, Cocco M, Palummo N et al. (2007). Gcet1 expression in endemic Burkitt lymphoma. Correlation with EBV status and IGH mutation pattern. VIRCHOWS ARCHIV. vol. 451, 119-119.

De Falco G, Leucci E, Lenze D, Piccaluga PP, Onnis A, Cerino G, Nyagol J, Luzzi A et al. (2007). Gene expression analysis identifies novel RBL2/P130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors. VIRCHOWS ARCHIV. vol. 451, 186-186.

Leucci E, De Falco G, Onnis A, Cerino G, Cocco M, Luzzi A, Crupi D, Tigli C et al.(2007). The role of the Cdk9/Cyclin T1 complex in T cell differentiation. J Cell Physiol vol. 212, (2) 411-415.

Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, Garosi L, Suriano G et al.(2007). Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol vol. 33, (4) 448-451.

Torricelli M, Giovannelli A, Leucci E, De Falco G, Reis FM, Imperatore A, Florio P, Petraglia F(2007). Labor (term and preterm) is associated with changes in the placental mRNA expression of corticotrophin-releasing factor. Reprod Sci vol. 14, (3) 241-245.

Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Suriano G, Vindigni C, Berardi A et al.(2007). High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology vol. 72, (3-4) 243-247.

Torricelli M, De Falco G, Florio P, Rossi M, Leucci E, Viganò P, Leoncini L, Petraglia F(2007). Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod vol. 22, (1) 92-96.

Leucci E, Onnis A, De Falco G, Luzzi A, Cerino G, Giordano A, Leoncini L(2007). Silencing human Rb2/p130 with shRNA. Cell Oncol vol. 29, (3) 265-268.

Florio P, Torricelli M, De Falco G, Leucci E, Giovannelli A, Gazzolo D, Severi FM, Bagnoli F et al.(2006). High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. J Hypertens vol. 24, (9) 1831-1840.

Leoncini L, Bellan C, De Falco G(2006). Retinoblastoma gene family expression in lymphoid tissues. Oncogene vol. 25, (38) 5309-5314.

Caracciolo V, Reiss K, Khalili K, De Falco G, Giordano A(2006). Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene vol. 25, (38) 5294-5301.

De Falco G, Giordano A(2006). pRb2/p130: a new candidate for retinoblastoma tumor formation. Oncogene vol. 25, (38) 5333-5340.

De Falco G, Comes F, Simone C(2006). pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene vol. 25, (38) 5244-5249.

Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, Dell'Anna A, Tiso E et al.(2006). Urocortin expression is downregulated in human endometrial carcinoma. J Endocrinol vol. 190, (1) 99-105.

Nyagol J, Leucci E, Onnis A, De Falco G, Tigli C, Sanseverino F, Torriccelli M, Palummo N et al.(2006). The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther vol. 5, (6) 684-690.

Vogiatzi P, De Falco G, Claudio PP, Giordano A(2006). How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. Cancer Biol Ther vol. 5, (4) 371-374.

Vogiatzi P, De Falco G(2005). Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Women's Oncology Review vol. 5, (4) 219-221.

Florio P, Torricelli M, Galleri L, De Falco G, Leucci E, Calonaci G, Picciolini E, Ambrosini G et al.(2005). High fetal urocortin levels at term and preterm labor. J CLIN ENDOCR METAB vol. 90, (9) 5361-5365.

De Falco G, Bellan C, D'Amuri A, Angeloni G, Leucci E, Giordano A, Leoncini L(2005). Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors. Cancer Biol Ther vol. 4, (3) 277-281.

Bellan C, De Falco G, Lazzi S, Micheli P, Vicidomini S, Schürfeld K, Amato T, Palumbo A et al.(2004). CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. J Pathol vol. 203, (4) 946-952.

Bellan C, De Falco G, Lazzi S, Leoncini L(2003). Pathologic aspects of AIDS malignancies. Oncogene vol. 22, (43) 6639-6645.

Bellan C, De Falco G, Lazzi S, Leoncini L(2003). Pathologic aspects of AIDS malignancies. Oncogene vol. 22, (42) 6639-6645.

De Falco G, Bellan C, Lazzi S, Claudio P, La Sala D, Cinti C, Tosi P, Giordano A et al.(2003). Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene vol. 22, (40) 6214-6219.

Bellan C, Lazzi S, De Falco G, Nyongo A, Giordano A, Leoncini L(2003). Burkitt's lymphoma: new insights into molecular pathogenesis. J Clin Pathol vol. 56, (3) 188-192.

Bellan C, De Falco G, Tosi GM, Lazzi S, Ferrari F, Morbini G, Bartolomei S, Toti P et al.(2002). Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci vol. 43, (12) 3602-3608.

De Falco G, Giordano A(2002). CDK9: from basal transcription to cancer and AIDS. Cancer Biol Ther vol. 1, (4) 342-347.

Lazzi S, Bellan C, De Falco G, Cinti C, Ferrari F, Nyongo A, Claudio PP, Tosi GM et al.(2002). Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Hum Pathol vol. 33, (7) 723-731.

Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G et al.(2002). Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene vol. 21, (26) 4137-4148.

De Falco G, Giordano A(2002). CDK9: From basal transcription to cancer and AIDS. CANCER BIOLOGY & THERAPY vol. 1, (4) 342-347.

De Falco G, Maria Neri L, De Falco M, Bellan C, Yu Z, De Luca A, Leoncini L, Giordano A(2002). Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines. Oncogene vol. 21, (49) 7464-7470.

De Falco M, Laforgia V, Fedele V, De Luca L, Cottone G, De Falco G, De Luca A(2001). Vasoactive intestinal peptide stimulation modulates the expression of Bcl-2 family members in the adrenal gland of the lizard Podarcis sicula. Histochem J vol. 33, (11-12) 639-645.

Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D, De Falco G et al.(2001). pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J Cell Physiol vol. 189, (1) 34-44.

De Falco G, Bagella L, Claudio PP, De Luca A, Fu Y, Calabretta B, Sala A, Giordano A(2000). Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene vol. 19, (3) 373-379.

Romano G, Kasten M, De Falco G, Micheli P, Khalili K, Giordano A(1999). Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression. JOURNAL OF CELLULAR BIOCHEMISTRY vol. 75, (3) 357-368.

Romano G, Kasten M, De Falco G, Micheli P, Khalili K, Giordano A(1999). Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression. J Cell Biochem vol. 75, (3) 357-368.

de Falco G, Giordano A(1998). CDK9 (PITALRE): a multifunctional cdc2-related kinase. J Cell Physiol vol. 177, (4) 501-506.

Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M et al.(1997). Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J Immunol vol. 158, (9) 4097-4103.

Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C et al.(1996). Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. J Biol Chem vol. 271, (37) 22479-22486.